<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1674" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1674/" /><meta name="ncbi_pagename" content="LMNA-Related Dilated Cardiomyopathy - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>LMNA-Related Dilated Cardiomyopathy - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="LMNA-Related Dilated Cardiomyopathy" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/07/07" /><meta name="citation_author" content="Ray E Hershberger" /><meta name="citation_author" content="Ana Morales" /><meta name="citation_pmid" content="20301717" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1674/" /><meta name="citation_keywords" content="CMD1A" /><meta name="citation_keywords" content="Dilated Cardiomyopathy 1A" /><meta name="citation_keywords" content="Prelamin-A/C" /><meta name="citation_keywords" content="LMNA" /><meta name="citation_keywords" content="LMNA-Related Dilated Cardiomyopathy" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="LMNA-Related Dilated Cardiomyopathy" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Ray E Hershberger" /><meta name="DC.Contributor" content="Ana Morales" /><meta name="DC.Date" content="2016/07/07" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1674/" /><meta name="description" content="LMNA-related dilated cardiomyopathy (DCM) is caused by pathogenic variants in LMNA and is characterized by left ventricular enlargement and/or reduced systolic function preceded or accompanied by significant conduction system disease and/or arrhythmias. LMNA-related DCM usually presents in early to mid-adulthood with symptomatic conduction system disease or arrhythmias, or with symptomatic DCM including heart failure or embolus from a left ventricular mural thrombus. Sudden cardiac death can occur, and in some instances is the presenting manifestation; sudden cardiac death may occur with minimal or no systolic dysfunction." /><meta name="og:title" content="LMNA-Related Dilated Cardiomyopathy" /><meta name="og:type" content="book" /><meta name="og:description" content="LMNA-related dilated cardiomyopathy (DCM) is caused by pathogenic variants in LMNA and is characterized by left ventricular enlargement and/or reduced systolic function preceded or accompanied by significant conduction system disease and/or arrhythmias. LMNA-related DCM usually presents in early to mid-adulthood with symptomatic conduction system disease or arrhythmias, or with symptomatic DCM including heart failure or embolus from a left ventricular mural thrombus. Sudden cardiac death can occur, and in some instances is the presenting manifestation; sudden cardiac death may occur with minimal or no systolic dysfunction." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1674/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/dcm-lmna/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1674/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8B6D76E03FDD2100000000087F02F7.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1674_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1674_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/mdef-cmd/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/lrrk2/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1674_"><span class="title" itemprop="name"><i>LMNA</i>-Related Dilated Cardiomyopathy</span></h1><p class="contrib-group"><span itemprop="author">Ray E Hershberger</span>, MD and <span itemprop="author">Ana Morales</span>, MS, CGC.</p><a data-jig="ncbitoggler" href="#__NBK1674_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1674_ai__"><div class="contrib half_rhythm"><span itemprop="author">Ray E Hershberger</span>, MD<div class="affiliation small">Professor of Medicine, Divisions of Human Genetics and Cardiovascular Medicine<br />The Ohio State University<br />Columbus, Ohio<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.cmuso@regrebhsreh.yar" class="oemail">ude.cmuso@regrebhsreh.yar</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Ana Morales</span>, MS, CGC<div class="affiliation small">Assistant Professor, Division of Human Genetics<br />The Ohio State University<br />Columbus, Ohio<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.cmuso@selarom.ana" class="oemail">ude.cmuso@selarom.ana</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">June 12, 2008</span>; Last Update: <span itemprop="dateModified">July 7, 2016</span>.</p><p><em>Estimated reading time: 24 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="dcm-lmna.Summary" itemprop="description"><h2 id="_dcm-lmna_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>LMNA</i>-related dilated cardiomyopathy (DCM) is caused by pathogenic variants in <i>LMNA</i> and is characterized by left ventricular enlargement and/or reduced systolic function preceded or accompanied by significant conduction system disease and/or arrhythmias. <i>LMNA</i>-related DCM usually presents in early to mid-adulthood with symptomatic conduction system disease or arrhythmias, or with symptomatic DCM including heart failure or embolus from a left ventricular mural thrombus. Sudden cardiac death can occur, and in some instances is the presenting manifestation; sudden cardiac death may occur with minimal or no systolic dysfunction.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p><i>LMNA</i> <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> identifies pathogenic variants in most individuals with <i>LMNA</i>-related DCM. Conduction system disease is detected by a 12-lead electrocardiogram (ECG); arrhythmias are detected by an ECG, 24-hour rhythm recording, or event monitor. Left ventricular enlargement is diagnosed with cardiac imaging; reduced systolic function is assessed by two-dimensional echocardiography, angiography, radioisotope scanning, or magnetic resonance imaging.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Chronic atrial fibrillation is treated initially with attempts to restore normal sinus rhythm, anticoagulation, and rate control. Symptomatic supraventricular arrhythmias are usually treated with pharmacologic therapy or ablation; symptomatic bradyarrhythmias or significant heart block is treated with an electronic pacemaker. Symptomatic ventricular arrhythmias, ventricular tachycardia, ventricular fibrillation, and resuscitated sudden cardiac death are treated with an implantable cardiac defibrillator (ICD) and drug therapy as needed. Because risk for sudden cardiac death in <i>LMNA</i>-related DCM accompanies heart block and bradyarrhythmias, ICD use (rather than just pacemaker use) has been recommended for all indications. Treatment of symptomatic DCM, including heart failure, is pharmacologic with ACE inhibitors, beta blockers, and/or anti-aldosterone agents. Progressive deterioration in left ventricular function is treated with an ICD, and some experts recommend anticoagulation. Cardiac transplantation or other advanced therapies may be considered for refractory disease in persons receiving comprehensive care from cardiovascular disease experts.</p><p><i>Surveillance:</i> Individuals with an <i>LMNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> who are found to have any ECG abnormality should undergo a cardiovascular evaluation for disease progression at least annually. Asymptomatic individuals with a pathogenic <i>LMNA</i> variant should undergo cardiovascular evaluation (medical history, physical examination, echocardiogram, and ECG) every one to two years and/or whenever new symptoms arise. In families with a known <i>LMNA</i> pathogenic variant, at-risk individuals for whom genetic testing is not possible may be offered yearly cardiovascular screening. At onset of new symptoms an immediate evaluation for evidence of DCM and/or conduction system disease is indicated regardless of genetic status.</p><p><i>Evaluation of relatives at risk:</i> To facilitate prompt diagnosis, targeted <i>LMNA</i> genetic testing when the family-specific <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is known; otherwise routine surveillance with cardiovascular screening tests.</p><p><i>Pregnancy management</i>: Pregnancy is contraindicated in women with DCM. Pregnant women with DCM should be followed by a high-risk obstetrician. At-risk women with unknown genetic status should undergo a cardiovascular evaluation and be offered <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a>, ideally prior to pregnancy.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>LMNA</i>-related DCM is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Some individuals diagnosed with <i>LMNA</i>-related DCM have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent; the proportion of cases caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is unknown. Each child of an individual with <i>LMNA</i>-related DCM has a 50% chance of inheriting the parent's pathogenic variant. Prenatal diagnosis for <i>LMNA</i>-related DCM is technically possible when the pathogenic variant in the family is known.</p></div></div><div id="dcm-lmna.Diagnosis"><h2 id="_dcm-lmna_Diagnosis_">Diagnosis</h2><div id="dcm-lmna.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>LMNA</i>-related dilated cardiomyopathy (DCM) <b>should be suspected</b> in individuals with a clinical diagnosis of <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a> DCM (etiology not attributed to coronary artery disease, structural heart disease, or other conditions that may cause DCM; see <a href="/books/n/gene/dcm-ov/">Dilated Cardiomyopathy Overview</a>), almost always in the setting of conduction system disease and/or supraventricular or ventricular arrhythmias.</p><p>The diagnosis of DCM is based on the principal findings of left ventricular enlargement and/or reduced systolic function (other causes of which have been excluded):</p><ul><li class="half_rhythm"><div><b>Left ventricular enlargement</b> is most commonly identified with two-dimensional echocardiography, optimally assessed by a height- and gender-based approach [<a class="bk_pop" href="#dcm-lmna.REF.vasan.1997.1863">Vasan et al 1997</a>]. Other testing modalities include cardiac magnetic resonance imaging (MRI) or computed tomography (CT).</div></li><li class="half_rhythm"><div><b>Reduced systolic function</b> is usually described as a reduction in left ventricular ejection fraction, which can be measured by two-dimensional echocardiography, angiography, radioisotope scanning, or MRI of left ventricular function. An ejection fraction of less than 50% is considered systolic dysfunction.</div></li></ul><p>Note: <i>LMNA</i>-related DCM is almost always associated with conduction system disease and/or arrhythmias that commonly occur prior to the development of heart failure symptoms. Clinicians should also be aware that in some cases the conduction system disease precedes any evidence of DCM (see <a href="#dcm-lmna.Clinical_Description">Clinical Description</a>).</p></div><div id="dcm-lmna.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>LMNA</i>-related DCM <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a> DCM, systolic dysfunction, or left ventricular enlargement of unknown cause by the identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>LMNA</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1674/table/dcm-lmna.T.molecular_genetic_testing_use/?report=objectonly" target="object" rid-figpopup="figdcmlmnaTmoleculargenetictestinguse" rid-ob="figobdcmlmnaTmoleculargenetictestinguse">Table 1</a>).</p><p>Molecular genetic testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>.</p><p>Because of the genetic heterogeneity of DCM, <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> is not recommended for a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</p><p>Instead, the most common molecular testing approach for DCM in the US is use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>LMNA</i> and other genes of interest (see <a href="#dcm-lmna.Differential_Diagnosis">Differential Diagnosis</a>). Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered if a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>LMNA</i> fails to confirm a diagnosis in an individual with suspected <i>LMNA</i>-related DCM. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or genes that results in a similar clinical presentation).</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="dcm-lmna.T.molecular_genetic_testing_use" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>LMNA</i>-Related Dilated Cardiomyopathy</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1674/table/dcm-lmna.T.molecular_genetic_testing_use/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__dcm-lmna.T.molecular_genetic_testing_use_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_dcm-lmna.T.molecular_genetic_testing_use_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_dcm-lmna.T.molecular_genetic_testing_use_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_dcm-lmna.T.molecular_genetic_testing_use_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_dcm-lmna.T.molecular_genetic_testing_use_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>LMNA</i></td><td headers="hd_h_dcm-lmna.T.molecular_genetic_testing_use_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_dcm-lmna.T.molecular_genetic_testing_use_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;99%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_dcm-lmna.T.molecular_genetic_testing_use_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_dcm-lmna.T.molecular_genetic_testing_use_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="dcm-lmna.TF.1.1"><p class="no_margin">See <a href="/books/NBK1674/#dcm-lmna.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="dcm-lmna.TF.1.2"><p class="no_margin">See <a href="#dcm-lmna.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="dcm-lmna.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="dcm-lmna.TF.1.4"><p class="no_margin">Almost all pathogenic variants identified to date have been <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, or splice-site variants.</p></div></dd><dt>5. </dt><dd><div id="dcm-lmna.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods that may be used include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="dcm-lmna.TF.1.6"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available. Duplication/deletion analysis may increase testing <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a>: two reports have identified <i>LMNA</i>-related DCM resulting from deletions [<a class="bk_pop" href="#dcm-lmna.REF.van_tintelen.2007b.2430">van Tintelen et al 2007b</a>, <a class="bk_pop" href="#dcm-lmna.REF.gupta.2010.365">Gupta et al 2010</a>].</p></div></dd></dl></div></div></div></div></div><div id="dcm-lmna.Clinical_Characteristics"><h2 id="_dcm-lmna_Clinical_Characteristics_">Clinical Characteristics</h2><div id="dcm-lmna.Clinical_Description"><h3>Clinical Description</h3><p><i>LMNA</i>-related dilated cardiomyopathy (DCM) is characterized by left ventricular enlargement and/or reduced systolic function frequently accompanied by significant conduction system disease.</p><p><b>Age of onset.</b> While <i>LMNA</i>-related DCM usually presents in adulthood either with conduction system disease commonly accompanied by arrhythmias or with symptomatic DCM (including heart failure or embolus from a left ventricular mural thrombus), it may also be present in asymptomatic individuals: DCM, conduction system disease, or arrhythmia may be discovered during a medical evaluation conducted for another reason (e.g., a routine preoperative ECG) or clinical screening of at-risk relatives.</p><p><b>Presenting signs, timing, and progression.</b> Family studies suggest that conduction system disease commonly precedes the development of DCM by a few years to a decade or more. In a study involving 64 individuals with an <i>LMNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the median time differential from ECG abnormalities to observed left ventricular dysfunction was seven years [<a class="bk_pop" href="#dcm-lmna.REF.brodt.2013.233">Brodt et al 2013</a>].</p><ul><li class="half_rhythm"><div><b>Conduction system involvement</b> usually starts with disease of the sinus node and/or atrioventricular node that can manifest as sinus bradycardia, sinus node arrest with junctional rhythms, or heart block (commonly first-degree heart block that progresses to second- and third-degree block). The following are also common:</div><ul><li class="half_rhythm"><div>Symptomatic bradyarrhythmias requiring cardiac pacemakers</div></li><li class="half_rhythm"><div>Supraventricular arrhythmias including atrial flutter, atrial fibrillation, supraventricular tachycardia, and the sick sinus syndrome (i.e., tachycardia-bradycardia syndrome)</div></li><li class="half_rhythm"><div>Ventricular arrhythmias including frequent premature ventricular contractions (PVCs), ventricular tachycardia, and ventricular fibrillation</div></li></ul></li><li class="half_rhythm"><div><b>Sudden cardiac death</b> may occur with progressive disease. Although more malignant, life-threatening arrhythmias may occur with longstanding and usually previously symptomatic DCM, sudden cardiac death can also be the presenting manifestation of <i>LMNA</i>-related DCM.</div></li><li class="half_rhythm"><div><b>Variable DCM</b>. Only mild to moderate left ventricular dilatation despite progressive disease has been noted by some investigators. Therefore, <i>LMNA</i>-related DCM may be an appropriate diagnosis in those with an <i>LMNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> who have clinical conduction system disease and/or arrhythmia prior to the left ventricular enlargement or with minimal or no systolic dysfunction.</div></li><li class="half_rhythm"><div><b>Skeletal muscle disorder</b>. Occasionally, individuals with <i>LMNA</i>-related cardiomyopathy also manifest signs or symptoms of skeletal myopathy, which may be associated with elevated serum creatine kinase (CK) concentration.</div></li></ul><p>Large prospective longitudinal studies to define the range of natural history of individuals with <i>LMNA</i> pathogenic variants have not yet been published.</p><p>Click <a href="/books/NBK1674/bin/dcm-lmna-cv_signs.pdf">here</a> (pdf) for clinical descriptions of the cardiovascular manifestations of <i>LMNA</i>-related DCM.</p></div><div id="dcm-lmna.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No specific <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have been established for <i>LMNA</i>-related DCM.</p><p>A few studies focusing on <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> type suggest a correlation between <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants and increased risk for sudden cardiac death [<a class="bk_pop" href="#dcm-lmna.REF.pasotti.2008.1250">Pasotti et al 2008</a>] and between non-<a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants (<a class="def" href="/books/n/gene/glossary/def-item/indel/">indel</a>, truncating, splice site) and risk for malignant ventricular arrhythmias.</p></div><div id="dcm-lmna.Penetrance"><h3>Penetrance</h3><p><i>LMNA</i>-related DCM demonstrates age-related <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> with onset in the third and fourth decades, so that by the seventh decade penetrance is considered greater than 90%-95%.</p></div><div id="dcm-lmna.Prevalence"><h3>Prevalence</h3><p>A population-based estimate of the prevalence of DCM of unknown cause is not available. A review has suggested that the frequency of DCM is equal to the established frequency of hypertrophic cardiomyopathy (1:500) or greater [<a class="bk_pop" href="#dcm-lmna.REF.hershberger.2013.531">Hershberger et al 2013</a>].</p><p>The frequency of <i>LMNA</i>-related DCM in persons with DCM of unknown cause (also referred to as <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a> dilated cardiomyopathy [IDC]) ranges from 5% to 10% of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> DCM and 2% to 5% of non-familial DCM [<a class="bk_pop" href="#dcm-lmna.REF.arbustini.2002.981">Arbustini et al 2002</a>, <a class="bk_pop" href="#dcm-lmna.REF.k_rkk_inen.2006.524">K&#x000e4;rkk&#x000e4;inen et al 2006</a>, <a class="bk_pop" href="#dcm-lmna.REF.parks.2008.161">Parks et al 2008</a>, <a class="bk_pop" href="#dcm-lmna.REF.perrot.2009.90">Perrot et al 2009</a>].</p></div></div><div id="dcm-lmna.Genetically_Related_Allelic_Dis"><h2 id="_dcm-lmna_Genetically_Related_Allelic_Dis_">Genetically Related (Allelic) Disorders</h2><p>Pathogenic variants in <i>LMNA</i> have been reported in individuals with a <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> consistent with <a href="/books/n/gene/arvd/">arrhythmogenic right ventricular cardiomyopathy</a> (ARVC) [<a class="bk_pop" href="#dcm-lmna.REF.quarta.2012.1128">Quarta et al 2012</a>]. Pathogenic variants have also been identified in several disorders of striated muscle, nerve, adipose, and vascular tissue, collectively referred to as the <b>laminopathies</b>. Laminopathies result primarily from pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, with occasional <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> and splice-site variants, as well as short insertions or deletions. A remarkable exception is the synonymous variant (a nucleotide change that does not alter the amino acid) in <i>LMNA</i> codon 608 (GGC changed to GGT that does not change the Gly608 residue) causing <a href="/books/n/gene/hgps/">Hutchinson-Gilford progeria</a>. Synonymous variants have also been suggested for limb-girdle muscular dystrophy type 1B [<a class="bk_pop" href="#dcm-lmna.REF.todorova.2003.e115">Todorova et al 2003</a>].</p><p>Types of laminopathies include the following:</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/arvd/"><b>Arrhythmogenic right ventricular dysplasia/cardiomyopathy</b></a>
<b>(ARVD/C),</b> characterized by progressive fibrofatty replacement of the myocardium that predisposes to ventricular tachycardia and sudden death. While initially described as primarily affecting the right ventricle, more recently biventricular involvement has been observed, with occasional presentations mimicking DCM. A resequencing study of 108 individuals with ARVD/C identified four <i>LMNA</i> pathogenic variants, two of them previously reported to cause DCM [<a class="bk_pop" href="#dcm-lmna.REF.quarta.2012.1128">Quarta et al 2012</a>].</div></li><li class="half_rhythm"><div><b>Muscular dystrophy</b></div><ul><li class="half_rhythm"><div>Autosomal dominant <a href="/books/n/gene/edmd/">Emery-Dreifuss muscular dystrophy</a>, a humero-peroneal muscular dystrophy, usually with adult onset. Cardiac conduction system disease is commonly observed.</div></li><li class="half_rhythm"><div>Limb-girdle muscular dystrophy type 1B. Dystrophy of the limb musculature, predominantly proximally. Cardiac conduction system disease is also commonly observed.</div></li></ul></li><li class="half_rhythm"><div><b>Neuropathy.</b> Autosomal recessive Charcot-Marie-Tooth disease type 2B1 (CMT2B1). See <a href="/books/n/gene/cmt/">Charcot-Marie-Tooth Neuropathy Overview</a>.</div></li><li class="half_rhythm"><div><b>Lipodystrophy</b> (OMIM <a href="http://omim.org/entry/151660" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">151660</a>). Autosomal dominant Dunnigan-type <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> partial lipodystrophy (FPLD2), in which adipocytes degenerate during puberty, followed by abnormal fat deposition, glucose intolerance, and late-onset diabetes mellitus [<a class="bk_pop" href="#dcm-lmna.REF.cao.2000.109">Cao &#x00026; Hegele 2000</a>, <a class="bk_pop" href="#dcm-lmna.REF.hegele.2000.652">Hegele et al 2000</a>, <a class="bk_pop" href="#dcm-lmna.REF.speckman.2000.1192">Speckman et al 2000</a>]. Most <i>LMNA</i> pathogenic variants causing FPLD2 involve arginine at amino acid residue 482.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/hgps/"><b>Hutchinson-Gilford progeria syndrome</b></a><b>.</b> Synonymous <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> pathogenic variants in codon 608 cause an aberrant <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> of the terminal 50 amino acids of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 11 [<a class="bk_pop" href="#dcm-lmna.REF.de_sandregiovannoli.2003.2055">De Sandre-Giovannoli et al 2003</a>, <a class="bk_pop" href="#dcm-lmna.REF.eriksson.2003.293">Eriksson et al 2003</a>, <a class="bk_pop" href="#dcm-lmna.REF.capell.2006.940">Capell &#x00026; Collins 2006</a>].</div></li><li class="half_rhythm"><div><b>Heart-hand syndrome, Slovenian type</b> (OMIM <a href="http://omim.org/entry/610140" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">610140</a>). A <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variant was reported in a Slovenian family segregating DCM with conduction system disease (CSD) and variable degrees of brachydactyly [<a class="bk_pop" href="#dcm-lmna.REF.renou.2008.666">Renou et al 2008</a>].</div></li><li class="half_rhythm"><div><b>Other related disorders.</b> See <a href="/books/n/gene/edmd/#edmd.Genetically_Related_Allelic_Disorde">Emery-Dreifuss Muscular Dystrophy, Genetically Related Disorders</a>.</div></li></ul></div><div id="dcm-lmna.Differential_Diagnosis"><h2 id="_dcm-lmna_Differential_Diagnosis_">Differential Diagnosis</h2><p>The differential diagnosis of <i>LMNA</i>-related dilated cardiomyopathy (DCM) relates to the general <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of DCM of unknown cause. Current evidence indicates that <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a> DCM (i.e., DCM of unknown cause) may be <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> (and therefore possibly genetic) in 20%-50% of cases [<a class="bk_pop" href="#dcm-lmna.REF.burkett.2005.969">Burkett &#x00026; Hershberger 2005</a>].</p><p>With a clear pattern of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> disease, a genetic cause of DCM may be established (see <a href="/books/n/gene/dcm-ov/">Dilated Cardiomyopathy Overview</a>). <i>LMNA</i>-related cardiomyopathy may be the most common known cause of familial DCM with prominent conduction system disease (see <a href="#dcm-lmna.Prevalence">Prevalence</a>).</p><p>In those in whom <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing fails to identify a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>LMNA</i> or another gene associated with DCM, physical examination to evaluate for extra-cardiac features (especially neuromuscular issues) or additional study of the cardiovascular findings may lead to a diagnosis of other disorders causing DCM and conduction system disease (CSD):</p><ul><li class="half_rhythm"><div><b><i>DES</i>-related myopathy.</b> While <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> DCM has been reported with pathogenic variants in <i>DES</i> [<a class="bk_pop" href="#dcm-lmna.REF.li.1999.461">Li et al 1999</a>], <i>DES-</i>related myopathy is characterized by DCM with conduction and neuromuscular disease involving desmin protein aggregates in cardiomyocytes and skeletal muscle cells. A clinical evaluation with focus on neuromuscular disease accompanied by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> is required to diagnose <i>DES</i>-related myopathy. <a class="bk_pop" href="#dcm-lmna.REF.van_spaendonckzwarts.2011.354">Van Spaendonck-Zwarts et al [2011]</a> reported that <i>DES</i> pathogenic variants in the 2B <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> correlate with isolated neurologic involvement whereas head and tail domain pathogenic variants correlate with an isolated cardiac <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Some individuals with <i>DES</i> pathogenic variants can present with mild conduction system disease [<a class="bk_pop" href="#dcm-lmna.REF.taylor.2007.1244">Taylor et al 2007</a>].</div></li><li class="half_rhythm"><div><b>Limb-girdle muscular dystrophy (LGMD type 1D).</b> Collectively describing a group of disorders involving varying degrees and forms of skeletal muscle disease with or without cardiac involvement, LGMD can be caused by pathogenic variants in several genes. A <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variant in <i>DES</i> was reported in a family with DCM, CSD, and proximal muscle involvement, constituting the LGMD1D subtype. A clinical evaluation with focus on neuromuscular disease accompanied by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> are required to diagnose LGMD1D. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/arvd/"><b>Arrhythmogenic right ventricular dysplasia/cardiomyopathy</b></a>
<b>(ARVD/C)</b> is characterized by progressive fibrofatty replacement of the myocardium that predisposes to ventricular tachycardia and sudden death. While involvement of <i>LMNA</i> pathogenic variants is reported in some cases (see <a href="#dcm-lmna.Genetically_Related_Allelic_Dis">Genetically Related Disorders</a>), most cases of ARVD/C are caused by rare variants encoding desmosomal proteins (see <a href="/books/n/gene/arvd/">ARVD/C</a>). A molecular evaluation along with a clinical evaluation focusing on cardiovascular findings [<a class="bk_pop" href="#dcm-lmna.REF.marcus.2010.806">Marcus et al 2010</a>] is usually required to diagnose ARVD/C.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/edmd/"><b>Emery-Dreifuss muscular dystrophy</b></a>
<b>(EDMD)</b> is characterized by the clinical triad of joint contractures that begin in early childhood; slowly progressive muscle weakness and wasting initially in a humero-peroneal distribution that later extends to the scapular and pelvic girdle muscles; and cardiac involvement that may manifest as palpitations, presyncope and syncope, poor exercise tolerance, and congestive heart failure. Age of onset, severity, and progression of muscle and cardiac involvement demonstrate both inter- and <a class="def" href="/books/n/gene/glossary/def-item/intrafamilial-variability/">intrafamilial variability</a>. Clinical variability ranges from early onset with severe presentation in childhood to late onset with slow progression in adulthood. In general, joint contractures appear during the first two decades, followed by muscle weakness and wasting. Cardiac involvement usually occurs after the second decade. The three genes in which pathogenic variants are known to cause EDMD are <i>EMD</i> (encoding emerin) and <i>FHL1</i> (encoding FHL1), which cause <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> EDMD (XL-EDMD); and <i>LMNA</i> (encoding lamin A and C), which causes <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> EDMD (AD-EDMD) and <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> EDMD (AR-EDMD). A clinical evaluation with focus on neuromuscular disease and molecular analysis is required to diagnose Emery-Dreifuss muscular dystrophy.</div></li></ul></div><div id="dcm-lmna.Management"><h2 id="_dcm-lmna_Management_">Management</h2><p><a href="http://www.sciencedirect.com/science/article/pii/S1071916409000281" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Guidelines</a> for the clinical management of individuals with <i>LMNA</i>-related DCM have been published [<a class="bk_pop" href="#dcm-lmna.REF.hershberger.2009">Hershberger et al 2009</a>].</p><div id="dcm-lmna.Evaluations_Following_Initial_D"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <i>LMNA</i>-related DCM, the following evaluations are recommended.</p><p><b>Comprehensive cardiovascular evaluation</b></p><ul><li class="half_rhythm"><div>Evaluation for conduction system disease and arrhythmia:</div><ul><li class="half_rhythm"><div>Personal and family history of presyncope, syncope, resuscitated sudden cardiac death, palpitations, and other symptoms of arrhythmia</div></li><li class="half_rhythm"><div>Follow up of abnormalities with additional testing as indicated (e.g., 24-hour monitoring or event monitors)</div></li><li class="half_rhythm"><div>Referral to a cardiologist or electrophysiologist for any indication of symptomatic disease</div></li><li class="half_rhythm"><div>Indicated in some patients: invasive electrophysiologic evaluation for conduction system disease</div></li></ul></li><li class="half_rhythm"><div>Evaluation for left ventricular dysfunction and DCM:</div><ul><li class="half_rhythm"><div>Family history for cardiomyopathy of any type, personal history of shortness of breath, dyspnea on exertion, paroxysmal nocturnal dyspnea, chest pain</div></li><li class="half_rhythm"><div>Assessment of left ventricular function (most commonly by two-dimensional echocardiography) to determine left ventricular dimension and function. Alternatively, MRI provides similar data, and radionuclide ventriculography provides a measure of the ejection fraction.</div></li></ul></li></ul><p><b>Measurement of serum CK concentration to evaluate for skeletal myopathy</b></p><ul><li class="half_rhythm"><div>In some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals elevated serum CK concentrations with or without a skeletal muscle myopathy similar to Emery-Dreifuss muscular dystrophy or limb-girdle muscular dystrophy is observed.</div></li><li class="half_rhythm"><div>If CK levels are elevated, an evaluation for skeletal muscle weakness, including neuromuscular evaluation, may be necessary.</div></li></ul><p><b>History and physical examination for signs and symptoms of skeletal myopathy.</b> If there is evidence of myopathy, refer to a neuromuscular disease specialist for evaluation.</p><p><b>Other.</b> Consultation with a clinical geneticist and/or genetic counselor is recommended.</p></div><div id="dcm-lmna.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>For the general approach to managing DCM, see <a href="/books/n/gene/dcm-ov/#dcm-ov.Management">Dilated Cardiomyopathy Overview, Management</a>.</p><p>The <a class="bk_pop" href="#dcm-lmna.REF.pasotti.2008.1250">Pasotti et al [2008]</a> report (see <a href="/books/NBK1674/bin/dcm-lmna-cv_signs.pdf">details</a>) provides the most longitudinal data on <i>LMNA-</i>related DCM: 94 individuals with an <i>LMNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> were followed for a median of 57 months (range: 36-107 months). In the report of Brodt et al, the progression from first observed conduction system disease to the onset of ventricular dysfunction in a subset of 64 individuals with <i>LMNA</i> variants was a median of seven years [<a class="bk_pop" href="#dcm-lmna.REF.brodt.2013.233">Brodt et al 2013</a>]. Additional reports of large prospective longitudinal natural history studies of <i>LMNA</i>-related DCM are not yet available.</p><p>The Heart Failure Society of America and Heart Rhythm Society (in conjunction with the European Heart Rhythm Association) have commissioned <a href="http://www.sciencedirect.com/science/article/pii/S1071916409000281" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">guideline documents</a> for the management of genetic cardiomyopathies that included specific mention of <i>LMNA</i>-related DCM [<a class="bk_pop" href="#dcm-lmna.REF.hershberger.2009">Hershberger et al 2009</a>, <a class="bk_pop" href="#dcm-lmna.REF.ackerman.2011.1077">Ackerman et al 2011</a>]. Elements of the guidelines include the following:</p><ul><li class="half_rhythm"><div>Because of the complexity of treatment interventions in <i>LMNA</i>-related DCM in symptomatic and asymptomatic individuals, referral to centers with special expertise in cardiovascular genetic medicine should be considered.</div></li><li class="half_rhythm"><div>Consider therapy based on cardiac <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (i.e., DCM or arrhythmia).</div></li><li class="half_rhythm"><div>With an established arrhythmia or known risk of arrhythmia, consider ICD implantation before the ejection fraction falls below 35%. Note that this recommendation was developed in the Heart Failure Society guidelines in large part because of the risk for lethal arrhythmias in persons with an <i>LMNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> who have systolic function well above a left ventricular ejection fraction of 35%, the usual measure of systolic dysfunction below which ICDs are indicated in most US guidelines.</div></li></ul><p>The management of <i>LMNA</i>-related DCM is focused on treatment of <b>conduction system disease</b>, <b>arrhythmia</b>, and <b>DCM</b>.</p><p><b>Cardiac conduction system disease and arrhythmias</b></p><ul><li class="half_rhythm"><div>Chronic atrial fibrillation unresponsive to cardioversion is treated with anticoagulants and agents for ventricular rate control.</div></li><li class="half_rhythm"><div>Other symptomatic supraventricular arrhythmias are treated with pharmacologic agents, and at times are augmented with electrophysiologic intervention (e.g., atrial or atrioventricular node ablations).</div></li><li class="half_rhythm"><div>Symptomatic bradyarrhythmias or asymptomatic but significant heart block is treated with an implantable electronic pacemaker. However, when a device is to be implanted, use of an implantable cardiac defibrillator (ICD) rather than an electronic pacemaker has been advocated and should be strongly considered, as the risk of mortality from sudden cardiac death usually accompanies supraventricular arrhythmias and conduction system disease. Sudden cardiac death presumably results from lethal tachyarrhythmias despite the presence of a pacemaker to treat bradyarrhythmias [<a class="bk_pop" href="#dcm-lmna.REF.van_berlo.2005.79">van Berlo et al 2005</a>, <a class="bk_pop" href="#dcm-lmna.REF.meune.2006.209">Meune et al 2006</a>], and for this reason use of an ICD has been advocated for <i>LMNA</i>-related cardiomyopathy with significant conduction system disease and/or arrhythmia regardless of the left ventricular ejection fraction [<a class="bk_pop" href="#dcm-lmna.REF.hershberger.2009">Hershberger et al 2009</a>].</div></li><li class="half_rhythm"><div>Symptomatic ventricular arrhythmias, ventricular tachycardia, ventricular fibrillation, and resuscitated sudden cardiac death are treated with an ICD and drug therapy as needed.</div></li><li class="half_rhythm"><div>When DCM is present and the left ventricular ejection fraction is less than 35%, an ICD should be implanted following the usual <a href="http://www.sciencedirect.com/science/article/pii/S0735109713021141" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">guidelines</a> [<a class="bk_pop" href="#dcm-lmna.REF.yancy.2013.e147">Yancy et al 2013</a>].</div></li></ul><p><b><i>LMNA</i>-related DCM</b></p><ul><li class="half_rhythm"><div>Treatment of symptomatic DCM, including heart failure, is pharmacologic with ACE inhibitors, beta blockers, diuretics, and other conventional approaches, as summarized in <a class="bk_pop" href="#dcm-lmna.REF.yancy.2013.e147">Yancy et al [2013]</a> (<a href="http://www.sciencedirect.com/science/article/pii/S0735109713021141" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">full text</a>).</div></li><li class="half_rhythm"><div>With progressive deterioration in left ventricular function (left ventricular ejection fraction &#x0003c;30%) while still in sinus rhythm, some experts recommend full anticoagulation to prevent the development of left ventricular mural thrombus and embolic events including stroke.</div></li><li class="half_rhythm"><div>Cardiac transplantation or other advanced therapies should be considered with progressive DCM, advancing heart failure, and otherwise refractory disease in persons receiving comprehensive cardiovascular care from experts in the field [<a class="bk_pop" href="#dcm-lmna.REF.yancy.2013.e147">Yancy et al 2013</a>].</div></li></ul></div><div id="dcm-lmna.Prevention_of_Secondary_Complic"><h3>Prevention of Secondary Complications</h3><p>Whether conventional medical therapy (e.g., ACE inhibitors, beta blockers) is able to ameliorate or prevent DCM or heart failure in <i>LMNA</i>-related DCM has not been formally tested and is therefore unknown.</p><p>Implantable cardiac defibrillators or pacemakers are highly effective in preventing sudden cardiac death.</p></div><div id="dcm-lmna.Surveillance"><h3>Surveillance</h3><p>Screening and identification of DCM before the onset of symptoms enables the initiation of medical therapy that may delay disease progression.</p><ul><li class="half_rhythm"><div>Individuals with an <i>LMNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> who are found to have any ECG abnormality should undergo a cardiovascular evaluation for disease progression at least annually [<a class="bk_pop" href="#dcm-lmna.REF.brodt.2013.233">Brodt et al 2013</a>]. This should include, minimally, an ECG, 24- or 48-hour rhythm monitoring, and measurement of ventricular function.</div></li><li class="half_rhythm"><div>Asymptomatic individuals with a pathogenic <i>LMNA</i> variant should undergo cardiovascular evaluation (medical history, physical examination, echocardiogram, and ECG) every one to two years and/or whenever new symptoms arise.</div></li></ul></div><div id="dcm-lmna.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Drugs (e.g., beta blockers, calcium channel blockers, others) that exacerbate heart block, if present, should be avoided in <i>LMNA</i>-related DCM unless an electronic pacemaker is in place.</p></div><div id="dcm-lmna.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>When the <i>LMNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in a family, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can be offered to relatives at risk in order to facilitate prompt diagnosis, surveillance, and treatment in those in whom the <i>LMNA</i> pathogenic variant has been detected.</p><p>If <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> is not possible, the first-degree relatives of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with <i>LMNA</i>-related DCM should be evaluated annually by medical history, physical examination, echocardiogram, and ECG to determine if any have detectable DCM and/or conduction system disease.</p><p>Note: Because the age of onset is variable and <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> is reduced, a normal baseline echocardiogram and ECG in a <a class="def" href="/books/n/gene/glossary/def-item/first-degree-relative/">first-degree relative</a> who has not undergone <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> does not rule out <i>LMNA</i>-related DCM in that individual, and the recommendations set forth in <a href="#dcm-lmna.Surveillance">Surveillance</a> should be followed.</p><p>Any abnormal cardiovascular test results in a relative of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with a known <i>LMNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> should be followed up with a full cardiovascular assessment to evaluate for any acquired causes of disease (e.g., coronary artery disease). Results on screening tests that do not meet criteria for DCM but do show some abnormality (e.g., left ventricular enlargement but normal function; decreased ejection fraction but normal-sized left ventricle) may reflect variable expression of <i>LMNA</i>-related DCM in that relative. Targeted genetic testing to clarify the diagnosis as well as close surveillance (e.g., cardiovascular testing every 1-2 years) for progression of cardiovascular disease is recommended for such individuals.</p><p>See <a href="#dcm-lmna.Related_Genetic_Counseling_Issu">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="dcm-lmna.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Pregnancy is contraindicated in women with DCM because of the significantly increased mortality with pregnancy in DCM. Women with DCM who become pregnant should be followed by a high-risk obstetrician. At-risk women with unknown genetic status should undergo a cardiovascular evaluation and be offered <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> prior to pregnancy.</p></div><div id="dcm-lmna.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="dcm-lmna.Genetic_Counseling"><h2 id="_dcm-lmna_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="dcm-lmna.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>LMNA</i>-related dilated cardiomyopathy (DCM) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="dcm-lmna.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Some individuals diagnosed with <i>LMNA</i>-related DCM have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with <i>LMNA</i>-related DCM may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The proportion of cases caused by a <i>de novo</i> pathogenic variant is unknown.</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of reportedly unaffected parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> include: review of medical history, physical examination, echocardiogram, and ECG to determine if a parent has detectable DCM and/or conduction system disease; and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in the proband. Evaluation of parents may determine that one is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> but has previously escaped diagnosis and/or has a milder phenotypic presentation, including evidence of DCM on echocardiogram without clinical heart failure symptoms (i.e., asymptomatic affected).</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with <i>LMNA</i>-related DCM may appear to be negative because of early death of the parent before phenotypic features are detectable, or before the onset of symptoms, late onset of the disease in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent, or non-<a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of the <i>LMNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband's parents.</div></li><li class="half_rhythm"><div>If one parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of inheriting the variant is 50%. However, because of variable expression and reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, no predictions can be made regarding age of onset, severity, or course of disease.</div></li><li class="half_rhythm"><div>When neither parent has clinical evidence of <i>LMNA</i>-related DCM, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is increased over the general population risk, but cannot be precisely calculated. Genetic testing may help to clarify risk. Recommendations for evaluation of sibs are included in <a href="#dcm-lmna.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a>.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the risk to sibs is slightly greater than that of the general population (though still &#x0003c;1%) because of the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> (germline mosaicism has not been reported to date).</div></li><li class="half_rhythm"><div>When the family-specific <i>LMNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is known, sibs may be offered genetic testing to help clarify risk. However, absence of the variant in an unaffected sib should be interpreted with caution as this test result does not rule out the possibility of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> DCM caused by an etiology other than mutation of <i>LMNA</i> [<a class="bk_pop" href="#dcm-lmna.REF.parks.2008.161">Parks et al 2008</a>, <a class="bk_pop" href="#dcm-lmna.REF.liu.2015.164">Liu et al 2015</a>].</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with <i>LMNA</i>-related DCM has a 50% chance of inheriting the parent's variant. However, because of variable expression and reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, no predictions can be made regarding age of onset, severity, or course of disease.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to other family members depends on the status of the proband's parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or has an <i>LMNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> despite being clinically asymptomatic, his or her family members may be at risk.</p></div><div id="dcm-lmna.Related_Genetic_Counseling_Issu"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#dcm-lmna.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family history.</b> A detailed three- to four-generation family history (including heart failure, DCM, cardiac transplantation, pacemakers or implantable cardiac defibrillators, unexplained sudden death, unexplained cardiac conduction system disease and/or arrhythmia, or unexplained stroke or other thromboembolic disease) should be obtained from relatives to assess the possibility of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> disease. Conduction system disease, particularly with pacemakers, is particularly suggestive of <i>LMNA</i>-related DCM.</p><p>Both sides of the family should be considered as possibly contributing. Families with dilated cardiomyopathy in both maternal and paternal lineages have been described [<a class="bk_pop" href="#dcm-lmna.REF.crispell.1999.837">Crispell et al 1999</a>, <a class="bk_pop" href="#dcm-lmna.REF.parks.2008.161">Parks et al 2008</a>, <a class="bk_pop" href="#dcm-lmna.REF.liu.2015.164">Liu et al 2015</a>], and experience has shown that regardless of an apparent inheritance pattern in a family, assumptions regarding maternal or paternal inheritance of pathogenic variants in genes causing <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> dilated cardiomyopathy in a given family may be unreliable and potentially misleading. Click <a href="/books/NBK1674/bin/dcm-lmna-cv_signs.pdf">here</a> (pdf) for discussion of <a class="bk_pop" href="#dcm-lmna.REF.parks.2008.161">Parks et al [2008]</a>.</p><p><b>Molecular genetic testing of at-risk asymptomatic adult relatives</b> of individuals with <i>LMNA</i>-related DCM is possible if <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has identified the specific <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> relative. Such testing should only be performed in the context of formal <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a>, and is not useful in predicting age of disease onset, severity, or rate of progression. Testing of asymptomatic at-risk individuals is considered predictive testing for predisposition to <i>LMNA</i>-related DCM, not diagnostic testing.</p><p><b>Molecular genetic testing of at-risk asymptomatic relatives younger than age 18 years.</b> Although the likelihood of clinically detectable <i>LMNA</i>-related DCM in pediatric cases is low [<a class="bk_pop" href="#dcm-lmna.REF.rampersaud.2011.39">Rampersaud et al 2011</a>; <a class="bk_pop" href="#dcm-lmna.REF.van_tintelen.2007a.1130">van Tintelen et al 2007a</a>; Authors, unpublished data], genetic testing should be offered as it can facilitate identification of at-risk children who may benefit from early treatment, potentially forestalling the development of advanced disease. In families with early-onset aggressive disease, identification of the <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> may guide more stringent clinical screening for asymptomatic but clinically detectable cardiovascular disease.</p><p>See the American Academy of Pediatrics and American College of Medical Genetics and Genomics <a href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">policy statement</a> for discussion of ethical and policy issues in genetic testing and screening of children.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy. Similarly, decisions about testing to determine the genetic status of at-risk asymptomatic family members are best made before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="dcm-lmna.Prenatal_Testing_and_Preimplant"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once an <i>LMNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for a pregnancy at increased risk for <i>LMNA</i>-related DCM are possible.</p><p>Differences in perspective exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="dcm-lmna.Resources"><h2 id="_dcm-lmna_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Cardiomyopathy UK</b></div><div>Chiltern Court</div><div>Asheridge Road</div><div>Unit 10</div><div>Chesham Buckinghamshire HP5 2PX</div><div>United Kingdom</div><div><b>Phone:</b> 0800 018 1024 (UK only); 0800 018 1024 (UK only)</div><div><b>Email:</b> info@cardiomyopathy.org</div><div><a href="http://www.cardiomyopathy.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cardiomyopathy.org</a></div></li><li class="half_rhythm"><div><b>Medline Plus</b></div><div><a href="http://www.nlm.nih.gov/medlineplus/ency/article/001105.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Cardiomyopathy</a></div></li><li class="half_rhythm"><div><b>Children's Cardiomyopathy Foundation (CCF)</b></div><div>PO Box 547</div><div>Tenafly NJ 07670</div><div><b>Phone:</b> 866-808-2873 (toll-free)</div><div><b>Fax:</b> 201-227-7016</div><div><b>Email:</b> info@childrenscardiomyopathy.org</div><div><a href="http://www.childrenscardiomyopathy.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.childrenscardiomyopathy.org</a></div></li></ul></div><div id="dcm-lmna.Molecular_Genetics"><h2 id="_dcm-lmna_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="dcm-lmna.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>LMNA-Related Dilated Cardiomyopathy: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1674/table/dcm-lmna.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__dcm-lmna.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_dcm-lmna.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_dcm-lmna.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_dcm-lmna.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_dcm-lmna.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_dcm-lmna.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_dcm-lmna.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_dcm-lmna.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/4000" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>LMNA</i></a></td><td headers="hd_b_dcm-lmna.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=4000" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1q22</a></td><td headers="hd_b_dcm-lmna.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P02545" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Prelamin-A<wbr style="display:inline-block"></wbr>​/C</a></td><td headers="hd_b_dcm-lmna.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.interfil.org/details.php?id=NM_170707" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Human Intermediate Filament Database LMNA (lamin C1)</a><br /><a href="http://www.interfil.org/details.php?id=NM_170707" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Human Intermediate Filament Database LMNA (lamin A)</a><br /><a href="http://www.interfil.org/details.php?id=NM_170707" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Human Intermediate Filament Database LMNA (lamin C2)</a><br /><a href="http://www.molgen.ua.ac.be/CMTMutations/Mutations/Contexts.cfm?ID=21" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">IPN Mutations, LMNA</a><br /><a href="http://www.umd.be/LMNA/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">The UMD-LMNA mutations database</a><br /><a href="https://databases.lovd.nl/shared/genes/LMNA" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LMNA homepage - Leiden Muscular Dystrophy pages</a></td><td headers="hd_b_dcm-lmna.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=LMNA" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LMNA</a></td><td headers="hd_b_dcm-lmna.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=LMNA[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LMNA</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="dcm-lmna.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="dcm-lmna.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for LMNA-Related Dilated Cardiomyopathy (<a href="/omim/115200,150330" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1674/table/dcm-lmna.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__dcm-lmna.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/115200" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">115200</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CARDIOMYOPATHY, DILATED, 1A; CMD1A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/150330" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">150330</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LAMIN A/C; LMNA</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>LMNA</i> comprises twelve exons. Alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 10 produces two proteins, lamin A and lamin C (see <b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a></b>). For a detailed summary of gene, splice variants, and protein information, see <a href="/books/NBK1674/#dcm-lmna.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> More than 200 sequence variants in <i>LMNA</i> have been reported (see <a href="http://www.dmd.nl/lmna_home.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Leiden Muscular Dystrophy site</a> or <a href="/clinvar/?term=LMNA%5Bgene%5D" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinVar</a>). <i>LMNA</i>-related dilated cardiomyopathy (DCM) results from <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, with occasional <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> or splice-site variants and short insertions or deletions of <i>LMNA</i>.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 10 produces two proteins: lamin C, with 572 amino acids (<a href="/nuccore/NM_005572.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_005572.3</a>; <a href="/protein/NP_005563.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_005563.1</a>) and lamin A (<a href="/nuccore/NM_170707.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_170707.2</a>; <a href="/protein/NP_733821.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_733821.1</a>), which is identical to lamin C for the first 566 amino acids, but has an additional 98 terminal amino acids (total of 664).</p><p>Both lamins A and C are structural proteins of the inner nuclear membrane and are found in many different tissues [<a class="bk_pop" href="#dcm-lmna.REF.capell.2006.940">Capell &#x00026; Collins 2006</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The mechanism of cellular injury that causes <i>LMNA</i>-related DCM remains incompletely understood. Because lamin A/C is a structural protein of the nuclear membrane, it has been suggested that fragility of the nuclear membrane in the setting of repetitive contraction of skeletal or cardiac muscle may predispose to nuclear injury and cellular apoptosis. An alternative hypothesis suggests that an abnormal lamin A/C protein may disrupt the chromatin/lamin-associated protein complex, thereby disturbing gene expression.</p></div><div id="dcm-lmna.References"><h2 id="_dcm-lmna_References_">References</h2><div id="dcm-lmna.Published_GuidelinesConsensus_S"><h3>Published Guidelines/Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF1">Committee on Bioethics, Committee on Genetics, and American College of Medical Genetics and Genomics Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Available <a href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2013. Accessed 10-11-18. [<a href="/pubmed/23428972" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23428972</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.hershberger.2009">Hershberger RE, Lindenfeld J, Mestroni L, Seidman CE, Taylor MR, Towbin JA; Heart Failure Society of America. Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline. Available <a href="http://www.sciencedirect.com/science/article/pii/S1071916409000281" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2009. Accessed 6-28-18. [<a href="/pubmed/19254666" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19254666</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF3">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset disorders. Available <a href="http://www.nsgc.org/p/bl/et/blogaid=860" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2017. Accessed 10-11-18.</div></li></ul></div><div id="dcm-lmna.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.ackerman.2011.1077">Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, Camm AJ, Ellinor PT, Gollob M, Hamilton R, Hershberger RE, Judge DP, Le Marec H, McKenna WJ, Schulze-Bahr E, Semsarian C, Towbin JA, Watkins H, Wilde A, Wolpert C, Zipes DP., Heart Rhythm Society (HRS).  European Heart Rhythm Association (EHRA). HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). <span><span class="ref-journal">Europace. </span>2011;<span class="ref-vol">13</span>:1077–109.</span> [<a href="/pubmed/21810866" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21810866</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.arbustini.2002.981">Arbustini E, Pilotto A, Repetto A, Grasso M, Negri A, Diegoli M, Campana C, Scelsi L, Baldini E, Gavazzi A, Tavazzi L. Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. <span><span class="ref-journal">J Am Coll Cardiol. </span>2002;<span class="ref-vol">39</span>:981–90.</span> [<a href="/pubmed/11897440" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11897440</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.brodt.2013.233">Brodt C, Siegfried JD, Hofmeyer M, Martel J, Rampersaud E, Li D, Morales A, Hershberger RE. Temporal relationship of conduction system disease and ventricular dysfunction in LMNA cardiomyopathy. <span><span class="ref-journal">J Card Fail. </span>2013;<span class="ref-vol">19</span>:233–9.</span> [<a href="/pmc/articles/PMC3699310/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3699310</span></a>] [<a href="/pubmed/23582089" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23582089</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.burkett.2005.969">Burkett EL, Hershberger RE. State of the Art: Clinical and genetic issues in familial dilated cardiomyopathy. <span><span class="ref-journal">J Am Coll Cardiol. </span>2005;<span class="ref-vol">45</span>:969–81.</span> [<a href="/pubmed/15808750" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15808750</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.cao.2000.109">Cao H, Hegele RA. Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan- type familial partial lipodystrophy. <span><span class="ref-journal">Hum Mol Genet. </span>2000;<span class="ref-vol">9</span>:109–12.</span> [<a href="/pubmed/10587585" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10587585</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.capell.2006.940">Capell BC, Collins FS. Human laminopathies: nuclei gone genetically awry. <span><span class="ref-journal">Nat Rev Genet. </span>2006;<span class="ref-vol">7</span>:940–52.</span> [<a href="/pubmed/17139325" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17139325</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.crispell.1999.837">Crispell KA, Wray A, Ni H, Nauman DJ, Hershberger RE. Clinical profiles of four large pedigrees with familial dilated cardiomyopathy: preliminary recommendations for clinical practice. <span><span class="ref-journal">J Am Coll Cardiol. </span>1999;<span class="ref-vol">34</span>:837–47.</span> [<a href="/pubmed/10483968" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10483968</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.de_sandregiovannoli.2003.2055">De Sandre-Giovannoli A, Bernard R, Cau P, Navarro C, Amiel J, Boccaccio I, Lyonnet S, Stewart CL, Munnich A, Le Merrer M, Levy N. Lamin a truncation in Hutchinson-Gilford progeria. <span><span class="ref-journal">Science. </span>2003;<span class="ref-vol">300</span>:2055.</span> [<a href="/pubmed/12702809" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12702809</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.eriksson.2003.293">Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, Scott L, Erdos MR, Robbins CM, Moses TY, Berglund P, Dutra A, Pak E, Durkin S, Csoka AB, Boehnke M, Glover TW, Collins FS. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. <span><span class="ref-journal">Nature. </span>2003;<span class="ref-vol">423</span>:293–8.</span> [<a href="/pubmed/12714972" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12714972</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.gupta.2010.365">Gupta P, Bilinska ZT, Sylvius N, Boudreau E, Veinot JP, Labib S, Bolongo PM, Hamza A, Jackson T, Ploski R, Walski M, Grzybowski J, Walczak E, Religa G, Fidzianska A, Tesson F. Genetic and ultrastructural studies in dilated cardiomyopathy patients: a large deletion in the lamin A/C gene is associated with cardiomyocyte nuclear envelope disruption. <span><span class="ref-journal">Basic Res Cardiol. </span>2010;<span class="ref-vol">105</span>:365–77.</span> [<a href="/pmc/articles/PMC3934843/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3934843</span></a>] [<a href="/pubmed/20127487" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20127487</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.hegele.2000.652">Hegele RA, Anderson CM, Wang J, Jones DC, Cao H. Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes. <span><span class="ref-journal">Genome Res. </span>2000;<span class="ref-vol">10</span>:652–8.</span> [<a href="/pmc/articles/PMC310873/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC310873</span></a>] [<a href="/pubmed/10810087" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10810087</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.hershberger.2013.531">Hershberger RE, Hedges DJ, Morales A. Dilated Cardiomyopathy: the complexity of a diverse genetic architecture. <span><span class="ref-journal">Nat Rev Cardiol. </span>2013;<span class="ref-vol">10</span>:531–47.</span> [<a href="/pubmed/23900355" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23900355</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.hershberger.2009.83">Hershberger RE, Lindenfeld J, Mestroni L, Seidman CE, Taylor MR, Towbin JA., Heart Failure Society of America.  Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline. <span><span class="ref-journal">J Card Fail. </span>2009;<span class="ref-vol">15</span>:83–97.</span> [<a href="/pubmed/19254666" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19254666</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.k_rkk_inen.2006.524">K&#x000e4;rkk&#x000e4;inen S, Reissell E, Heli&#x000f6; T, Kaartinen M, Tuomainen P, Toivonen L, Kuusisto J, Kupari M, Nieminen MS, Laakso M, Peuhkurinen K. Novel mutations in the lamin A/C gene in heart transplant recipients with end stage dilated cardiomyopathy. <span><span class="ref-journal">Heart. </span>2006;<span class="ref-vol">92</span>:524–6.</span> [<a href="/pmc/articles/PMC1860858/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1860858</span></a>] [<a href="/pubmed/16537768" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16537768</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.li.1999.461">Li D, Tapscoft T, Gonzalez O, Burch PE, Qui&#x000f1;ones MA, Zoghbi WA, Hill R, Bachinski LL, Mann DL, Roberts R. Desmin mutation responsible for idiopathic dilated cardiomyopathy. <span><span class="ref-journal">Circulation. </span>1999;<span class="ref-vol">100</span>:461–4.</span> [<a href="/pubmed/10430757" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10430757</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.liu.2015.164">Liu GS, Morales A, Vafiadaki E, Lam CK, Cai WF, Haghighi K, Adly G, Hershberger RE, Kranias E. A novel human R25C-phospholambanmutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia. <span><span class="ref-journal">Cardiovasc Res. </span>2015;<span class="ref-vol">107</span>:164–74.</span> [<a href="/pmc/articles/PMC4490203/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4490203</span></a>] [<a href="/pubmed/25852082" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25852082</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.marcus.2010.806">Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, Calkins H, Corrado D, Cox MG, Daubert JP, Fontaine G, Gear K, Hauer R, Nava A, Picard MH, Protonotarios N, Saffitz JE, Sanborn DM, Steinberg JS, Tandri H, Thiene G, Towbin JA, Tsatsopoulou A, Wichter T, Zareba W. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. <span><span class="ref-journal">Eur Heart J. </span>2010;<span class="ref-vol">31</span>:806–14.</span> [<a href="/pmc/articles/PMC2848326/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2848326</span></a>] [<a href="/pubmed/20172912" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20172912</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.meune.2006.209">Meune C, van Berlo JH, Anselme F, Bonne G, Pinto YM, Duboc D. Primary prevention of sudden death in patients with lamin A/C gene mutations. <span><span class="ref-journal">N Engl J Med. </span>2006;<span class="ref-vol">354</span>:209–10.</span> [<a href="/pubmed/16407522" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16407522</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.parks.2008.161">Parks SB, Kushner JD, Nauman D, Burgess D, Ludwigsen S, Peterson A, Li D, Jakobs PM, Litt M, Porter CB, Rahko PS, Hershberger RE. Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or idiopathic dilated cardiomyopathy. <span><span class="ref-journal">Am Heart J. </span>2008;<span class="ref-vol">156</span>:161–9.</span> [<a href="/pmc/articles/PMC2527054/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2527054</span></a>] [<a href="/pubmed/18585512" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18585512</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.pasotti.2008.1250">Pasotti M, Klersy C, Pilotto A, Marziliano N, Rapezzi C, Serio A, Mannarino S, Gambarin F, Favalli V, Grasso M, Agozzino M, Campana C, Gavazzi A, Febo O, Marini M, Landolina M, Mortara A, Piccolo G, Vigan&#x000f2; M, Tavazzi L, Arbustini E. Long-term outcome and risk stratification in dilated cardiolaminopathies. <span><span class="ref-journal">J Am Coll Cardiol. </span>2008;<span class="ref-vol">52</span>:1250–60.</span> [<a href="/pubmed/18926329" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18926329</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.perrot.2009.90">Perrot A, Hussein S, Ruppert V, Schmidt HH, Wehnert MS, Duong NT, Posch MG, Panek A, Dietz R, Kindermann I, B&#x000f6;hm M, Michalewska-Wludarczyk A, Richter A, Maisch B, Pankuweit S, Ozcelik C. Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy. <span><span class="ref-journal">Basic Res Cardiol. </span>2009;<span class="ref-vol">104</span>:90–9.</span> [<a href="/pubmed/18795223" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18795223</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.quarta.2012.1128">Quarta G, Syrris P, Ashworth M, Jenkins S, Zuborne Alapi K, Morgan J, Muir A, Pantazis A, McKenna WJ, Elliott PM. Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy. <span><span class="ref-journal">Eur Heart J. </span>2012;<span class="ref-vol">33</span>:1128–36.</span> [<a href="/pubmed/22199124" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22199124</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.rampersaud.2011.39">Rampersaud E, Siegfried JD, Norton N, Li D, Martin E, Hershberger RE. Rare variant mutations identified in pediatric patients with dilated cardiomyopathy. <span><span class="ref-journal">Prog Pediatr Cardiol. </span>2011;<span class="ref-vol">31</span>:39–47.</span> [<a href="/pmc/articles/PMC3072577/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3072577</span></a>] [<a href="/pubmed/21483645" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21483645</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.renou.2008.666">Renou L, Stora S, Yaou RB, Volk M, Sinkovec M, Demay L, Richard P, Peterlin B, Bonne G. Heart-hand syndrome of Slovenian type: a new kind of laminopathy. <span><span class="ref-journal">J Med Genet. </span>2008;<span class="ref-vol">45</span>:666–71.</span> [<a href="/pubmed/18611980" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18611980</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.speckman.2000.1192">Speckman RA, Garg A, Du F, Bennett L, Veile R, Arioglu E, Taylor SI, Lovett M, Bowcock AM. Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C. <span><span class="ref-journal">Am J Hum Genet. </span>2000;<span class="ref-vol">66</span>:1192–8.</span> [<a href="/pmc/articles/PMC1288186/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1288186</span></a>] [<a href="/pubmed/10739751" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10739751</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.taylor.2007.1244">Taylor MR, Slavov D, Ku L, Di Lenarda A, Sinagra G, Carniel E, Haubold K, Boucek MM, Ferguson D, Graw SL, Zhu X, Cavanaugh J, Sucharov CC, Long CS, Bristow MR, Lavori P, Mestroni L. Familial Cardiomyopathy Registry; BEST (Beta-Blocker Evaluation of Survival Trial) DNA Bank. Prevalence of desmin mutations in dilated cardiomyopathy. <span><span class="ref-journal">Circulation. </span>2007;<span class="ref-vol">115</span>:1244–51.</span> [<a href="/pubmed/17325244" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17325244</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.todorova.2003.e115">Todorova A, Halliger-Keller B, Walter MC, Dabauvalle MC, Lochmuller H, Muller CR. A synonymous codon change in the LMNA gene alters mRNA splicing and causes limb girdle muscular dystrophy type 1B. <span><span class="ref-journal">J Med Genet. </span>2003;<span class="ref-vol">40</span>:e115.</span> [<a href="/pmc/articles/PMC1735280/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735280</span></a>] [<a href="/pubmed/14569138" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14569138</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.van_berlo.2005.79">van Berlo JH, de Voogt WG, van der Kooi AJ, van Tintelen JP, Bonne G, Yaou RB, Duboc D, Rossenbacker T, Heidb&#x000fc;chel H, de Visser M, Crijns HJ, Pinto YM. Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? <span><span class="ref-journal">J Mol Med. </span>2005;<span class="ref-vol">83</span>:79–83.</span> [<a href="/pubmed/15551023" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15551023</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.van_spaendonckzwarts.2011.354">van Spaendonck-Zwarts KY, van Hessem L, Jongbloed JD, de Walle HE, Capetanaki Y, van der Kooi AJ, van Langen IM, van den Berg MP, van Tintelen JP. Desmin-related myopathy. <span><span class="ref-journal">Clin Genet. </span>2011;<span class="ref-vol">80</span>:354–66.</span> [<a href="/pubmed/20718792" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20718792</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.van_tintelen.2007a.1130">van Tintelen JP, Hofstra RM, Katerberg H, Rossenbacker T, Wiesfeld AC, du Marchie Sarvaas GJ, Wilde AA, van Langen IM, Nannenberg EA, van der Kooi AJ, Kraak M, van Gelder IC, van Veldhuisen DJ, Vos Y, van den Berg MP. Working Group on Inherited Cardiac Disorders, line 27/50, Interuniversity Cardiology Institute of The Netherlands. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics. <span><span class="ref-journal">Am Heart J. </span>2007a;<span class="ref-vol">154</span>:1130–9.</span> [<a href="/pubmed/18035086" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18035086</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.van_tintelen.2007b.2430">van Tintelen JP, Tio RA, Kerstjens-Frederikse WS, van Berlo JH, Boven LG, Suurmeijer AJ, White SJ, den Dunnen JT, te Meerman GJ, Vos YJ, van der Hout AH, Osinga J, van den Berg MP, van Veldhuisen DJ, Buys CH, Hofstra RM, Pinto YM. Severe myocardial fibrosis caused by a deletion of the 5' end of the lamin A/C gene. <span><span class="ref-journal">J Am Coll Cardiol. </span>2007b;<span class="ref-vol">49</span>:2430–9.</span> [<a href="/pubmed/17599607" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17599607</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.vasan.1997.1863">Vasan RS, Larson MG, Levy D, Evans JC, Benjamin EJ. Distribution and categorization of echocardiographic measurements in relation to reference limits: the Framingham Heart Study: formulation of a height- and sex-specific classification and its prospective validation. <span><span class="ref-journal">Circulation. </span>1997;<span class="ref-vol">96</span>:1863–73.</span> [<a href="/pubmed/9323074" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9323074</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.yancy.2013.e147">Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL., American College of Cardiology Foundation.  American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. <span><span class="ref-journal">J Am Coll Cardiol. </span>2013;<span class="ref-vol">62</span>:e147–239.</span> [<a href="/pubmed/23747642" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23747642</span></a>]</div></li></ul></div><div id="dcm-lmna.Suggested_Reading"><h3>Suggested Reading</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="dcm-lmna.REF.schreiber.2013.1365">Schreiber KH, Kennedy BK. When lamins go bad: nuclear structure and disease. <span><span class="ref-journal">Cell. </span>2013;<span class="ref-vol">152</span>:1365–75.</span> [<a href="/pmc/articles/PMC3706202/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3706202</span></a>] [<a href="/pubmed/23498943" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23498943</span></a>]</div></li></ul></div></div><div id="dcm-lmna.Chapter_Notes"><h2 id="_dcm-lmna_Chapter_Notes_">Chapter Notes</h2><div id="dcm-lmna.Author_Notes"><h3>Author Notes</h3><p>Website: <a href="http://www.DCMProject.com" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Dilated Cardiomyopathy Research Project</a></p></div><div id="dcm-lmna.Author_History"><h3>Author History</h3><p>Jason Cowan, MS; University of Miami Miller School of Medicine (2008-2011)<br />Ray E Hershberger, MD (2008-present)<br />Ana Morales, MS, CGC (2008-2011; 2013-present)</p></div><div id="dcm-lmna.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>7 July 2016 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>19 September 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>5 April 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>12 June 2008 (me) Review posted live</div></li><li class="half_rhythm"><div>7 January 2008 (rh) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1674</span><span class="label">PMID: <a href="/pubmed/20301717" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301717</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/mdef-cmd/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/lrrk2/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1674&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1674/?report=reader">PubReader</a></li><li><a href="/books/NBK1674/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1674" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1674" style="display:none" title="Cite this Page"><div class="bk_tt">Hershberger RE, Morales A. LMNA-Related Dilated Cardiomyopathy. 2008 Jun 12 [Updated 2016 Jul 7]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1674/pdf/Bookshelf_NBK1674.pdf">PDF version of this page</a> (457K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#dcm-lmna.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#dcm-lmna.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#dcm-lmna.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#dcm-lmna.Genetically_Related_Allelic_Dis" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#dcm-lmna.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#dcm-lmna.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#dcm-lmna.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#dcm-lmna.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#dcm-lmna.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#dcm-lmna.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#dcm-lmna.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4000[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">LMNA</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1674+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1459072" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1459072" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1459072" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1459072" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301466" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Catecholaminergic Polymorphic Ventricular Tachycardia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Catecholaminergic Polymorphic Ventricular Tachycardia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Napolitano C, Priori SG, Bloise R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301298" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dystrophinopathies</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dystrophinopathies<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Darras BT, Urion DK, Ghosh PS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301609" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Emery-Dreifuss Muscular Dystrophy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Emery-Dreifuss Muscular Dystrophy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bonne G, Leturcq F, Ben Yaou R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23074464" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.</a><span class="source">[Ont Health Technol Assess Ser....]</span><div class="brieflinkpop offscreen_noflow">Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Medical Advisory Secretariat.. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Ont Health Technol Assess Ser. 2005; 5(13):1-60. Epub 2005 Sep 1.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301310" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Arrhythmogenic Right Ventricular Cardiomyopathy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Arrhythmogenic Right Ventricular Cardiomyopathy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">McNally E, MacLeod H, Dellefave-Castillo L. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301717" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301717" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0413ebdde0891169c74dfb">LMNA-Related Dilated Cardiomyopathy - GeneReviews®</a><div class="ralinkpop offscreen_noflow">LMNA-Related Dilated Cardiomyopathy - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:59:07-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8B6D76E03FDD2100000000087F02F7&amp;ncbi_session=CE8B6D76E0413EA1_2175SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1674%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1674&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1674/&amp;ncbi_pagename=LMNA-Related Dilated Cardiomyopathy - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8B6D76E0413EA1_2175SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>